James Woodrow Johnt, MD in Scottsboro, AL - Preventive Medicine

James Woodrow Johnt, MD is a Preventive Medicine - Occupational Medicine physician based in Scottsboro, Alabama. James Woodrow Johnt is licensed to practice in Alabama (license number 21484) and his current practice location is 380 Woods Cove Rd, Scottsboro, Alabama. He can be reached at his office (for appointments etc.) via phone at (256) 218-3860.

NPI number for James Woodrow Johnt is 1316933997 and his current mailing address is 380 Woods Cove Rd, Scottsboro, Alabama. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1316933997.

Contact Information

	James Woodrow Johnt, MD
	380 Woods Cove Rd, Scottsboro, AL 35768-2428
	(256) 218-3860
	(256) 218-3817

Physician's Profile

Full Name	James Woodrow Johnt
Gender	Male
Speciality	Preventive Medicine - Occupational Medicine
Location	380 Woods Cove Rd, Scottsboro, Alabama
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1316933997
Provider Enumeration Date: 09/20/2005
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for James Woodrow Johnt such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1316933997	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
2083X0100X	Preventive Medicine - Occupational Medicine	21484 (Alabama)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. James Woodrow Johnt is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
James Woodrow Johnt, MD 380 Woods Cove Rd, Scottsboro, AL 35768-2428 Ph: (256) 218-3860	James Woodrow Johnt, MD 380 Woods Cove Rd, Scottsboro, AL 35768-2428 Ph: (256) 218-3860

News Archive

IDMC reviews data from Nanobiotix's NBTXR3 Phase I study on advanced soft tissue sarcoma

Nanobiotix, announced today that the Independent Data Monitoring Committee (IDMC) has reviewed the data of the first 6 patients treated in the phase I Study with the lead product NBTXR3 for the treatment of advanced Soft Tissue Sarcoma of the extremity. Based on the review of the safety data, the IDMC has unanimously recommended continuing the enrollment in the study according to the protocol. This trial is realized in the Institut Gustave Roussy, France.

Okayama University e-Bulletin highlights role of designer DNA-binding proteins to fight viral infections in agriculture, medicine

This issue includes a feature on designer DNA-binding proteins to combat viral infections in agriculture and medicine; news items include updates of official opening of the Okayama University Silicon Valley Office at Fremont (CA), and international collaboration work with Xiamen University; research highlights on immunizing plants; identification of gene Vrn-D4 for enabling wheat to adapt to areas with warm winters; importance of introgression on intra-specific genetic differentiation and adaptive divergence; an interesting twist on supercooled liquid water; and manufacturing denim in Okayama.

Susan Tolle to be awarded 2014 MacLean Center Prize in Clinical Ethics

The 2014 MacLean Center Prize in Clinical Ethics, an award of $50,000, will be presented to Susan Tolle, MD, a former MacLean Center fellow who has pioneered efforts to improve communication between health care providers and patients regarding end-of-life care.

E-cigarette use may be linked to higher odds of erectile dysfunction regardless of smoking history

Smoking has long been associated with Erectile Dysfunction (ED) and Cardiovascular Disease (CVD). However, little research has explored if there is a similar association among men who use Electronic Nicotine Delivery Systems (ENDS), commonly referred to as e-cigarettes.

Magnetic resonance imaging may predict survival in patients with advanced rectal cancer

A new study has shown that magnetic resonance imaging (MRI) used to evaluate responses to pre-surgery (neo-adjuvant) chemotherapy or radiation may predict survival among patients with advanced rectal cancer.

James Woodrow Johnt, MD - Preventive Medicine in Scottsboro, AL